文献
J-GLOBAL ID:201802265952703421
整理番号:18A0275900
ラパチニブ,パゾパニブ,レゴラフェニブ及びソラフェニブによるヒトUDP-グルクロノシルトランスフェラーゼ酵素の阻害:高ビリルビン血症との関連【Powered by NICT】
Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia
著者 (13件):
Miners John O.
(Department of Clinical Pharmacology, Flinders University School of Medicine, Adelaide, Australia)
,
Miners John O.
(Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia)
,
Chau Nuy
(Department of Clinical Pharmacology, Flinders University School of Medicine, Adelaide, Australia)
,
Rowland Andrew
(Department of Clinical Pharmacology, Flinders University School of Medicine, Adelaide, Australia)
,
Rowland Andrew
(Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia)
,
Burns Kushari
(Department of Clinical Pharmacology, Flinders University School of Medicine, Adelaide, Australia)
,
McKinnon Ross A.
(Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia)
,
Mackenzie Peter I.
(Department of Clinical Pharmacology, Flinders University School of Medicine, Adelaide, Australia)
,
Mackenzie Peter I.
(Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia)
,
Tucker Geoffrey T.
(Department of Human Metabolism, Medical and Biological Sciences (Emeritus), University of Sheffield, Sheffield, United Kingdom)
,
Knights Kathleen M.
(Department of Clinical Pharmacology, Flinders University School of Medicine, Adelaide, Australia)
,
Kichenadasse Ganessan
(Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia)
,
Kichenadasse Ganessan
(Department of Oncology, Flinders Medical Centre, Bedford Park, Australia)
資料名:
Biochemical Pharmacology
(Biochemical Pharmacology)
巻:
129
ページ:
85-95
発行年:
2017年
JST資料番号:
B0128A
ISSN:
0006-2952
CODEN:
BCPCA6
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)